Abstract
Background The rate at which different portions of the eye ages can be measured using eye fungus and optical coherence tomography (OCT) images; however, their genetic and environmental contributors have been elusive.
Methods We built an eye age predictor by training convolutional neural networks to predict age from 175,000 eye fundus and OCT images from participants of the UK Biobank cohort, capturing two different dimensions of eye (retinal, macula, fovea) aging. We performed a genome-wide association study (GWAS) and high-throughput epidemiology to identify novel genetic and environmental variables associated with the new age predictor, finding variables associated with accelerated eye aging.
Findings Fundus-based and OCT-based eye aging capture different dimensions of eye aging, whose combination predicted chronological age with an R2 and mean absolute error of 83.6±0.6%/2.62±0.05 years. In comparison, the fundus-based and OCT-based predictor alone predicted age with R2 of 76.6±1.3% vs. 70.8±1.2% respectively. Accelerated eye fundus- and OCT-measured accelerated aging has a significant genetic component, with heritability (total contribution of GWAS variants) of 26 and 23% respectively. For eye fundus measured aging, we report novel variants in the FAM150B gene (ALKAL2, or ALK ligand 2) (p<1×10-150); for OCT-measured eye aging, we found variants in genes such as CFH (complement factor H), COL4A4 (type 4 collagen), and RLBP (retinaldehyde binding protein 1, all p<1×10-20). Eye accelerated aging is also associated with behaviors and socioeconomic status, such as sleep deprivation and lower income.
Conclusions Our new deep-learning-based digital readouts, the best eye aging predictor to date, suggest a biological basis of eye aging. These new data can be harnessed for scalable genetic and epidemiological dissection and discovery of aging specific to different components of the eye and their relationship with different diseases of aging.
Funding National Institutes of Health, National Science Foundation, MassCATS, Sanofi. Funders had no role in the project.
Evidence before this study We performed a search on NCBI PubMed and Google Scholar searching for the terms, “eye aging”, “optical coherence tomography” (OCT), “fundus”, and/or “deep learning”. We found others have shown feasibility of predicting chronological age from eye image modalities, finding five publications that demonstrated chronological age may be predicted from images inside and outside of the eye, with mean absolute errors ranging from 2.3-5.82 years.
Added value of this study Our new eye age predictor combines both OCT and fundus images to assemble the most accurate fundus/OCT age predictor to date (mean absolute error of 2.62 years). Second, we have identified new genetic loci (e.g., in FAM150B) and epidemiological associations with eye accelerated age, highlighting the biological and environmental correlates of eye age, elusive in other investigations and made scalable by deep learning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NIEHS R00 ES023504 NIEHS R21 ES25052. NIAID R01 AI127250 NSF 163870 MassCATS, Massachusetts Life Science Center Sanofi The funders had no role in the study design or drafting of the manuscript(s).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Harvard internal review board (IRB) deemed the research as non-human subjects research (IRB: IRB16-2145).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵+ Co-second authors
GWAS updated to include imputed data and annotations refreshed using software package FUMA.
Data Availability
We used the UK Biobank (project ID: 52887). The code can be found at https://github.com/Deep-Learning-and-Aging. The results can be interactively and extensively explored at https://www.multidimensionality-of-aging.net/. We will make the biological age phenotypes available through UK Biobank upon publication. The GWAS results can be found at https://www.dropbox.com/s/59e9ojl3wu8qie9/Multidimensionality_of_aging-GWAS_results.zip?dl=0.
